These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 2448373)

  • 1. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
    Sato S; Qian JH; Kokudo S; Ikegami R; Suda T; Hamaoka T; Fujiwara H
    J Immunol; 1988 Feb; 140(3):717-22. PubMed ID: 2448373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
    Fujiwara H; Qian JH; Satoh S; Kokudo S; Ikegami R; Hamaoka T
    J Immunol; 1986 Apr; 136(8):2763-8. PubMed ID: 2420865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
    Qian J; Hashimoto T; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells.
    Sano S; Suda T; Qian JH; Sato S; Ikegami R; Hamaoka T; Fujiwara H
    J Immunol; 1987 Dec; 139(11):3652-9. PubMed ID: 3680947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    J Surg Res; 2002 May; 104(1):29-35. PubMed ID: 11971674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
    Margenthaler JA; Kataoka M; Flye WM
    J Surg Res; 2004 Jun; 119(2):107-12. PubMed ID: 15145690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of suppression of alloreactive capacity following intravenous injection of neuraminidase-treated allogeneic cells by co-injection of agents competing for asialoglycoprotein receptor.
    Suda T; Sano S; Hori S; Azuma T; Tateishi N; Hamaoka T; Fujiwara H
    Reg Immunol; 1988; 1(1):24-31. PubMed ID: 3275127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-receptor antibody-induced suppression of murine H-Y-specific delayed-type hypersensitivity responses.
    Sunday ME; Weinberger JZ; Wolff S; Dorf ME
    Eur J Immunol; 1981 Aug; 11(8):626-31. PubMed ID: 6168472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF).
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: possible explanation for the mechanism of tolerance induction by portal vein injection.
    Zhang Y; Yasumizu R; Sugiura K; Hashimoto F; Amoh Y; Lian Z; Cherry ; Nishio N; Ikehara S
    Eur J Immunol; 1994 Jul; 24(7):1558-65. PubMed ID: 7913037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses.
    Jenkins MK; Miller SD
    J Mol Cell Immunol; 1985; 2(1):1-13. PubMed ID: 2978221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenetic analysis of tolerance induction in anti-alloantigen delayed type hypersensitivity responses by portal venous pre-inoculation with allogeneic cells.
    Shimizu J; Ogata M; Qian JH; Sato S; Kokudo S; Hamaoka T; Fujiwara H
    Microbiol Immunol; 1987; 31(4):367-74. PubMed ID: 3475532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of tolerance induction of tumor-specific delayed-type hypersensitivity responses by intravenous inoculation of tumor cells.
    Sato S; Fukuzawa M; Nakajima H; Ogata M; Kosugi A; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1985 Nov; 76(11):1099-106. PubMed ID: 2935516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
    Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory pathways in adult responder mice. II. Regulation of delayed-type hypersensitivity responses by GAT-specific suppressor factors present in GAT-tolerant adult responder mice.
    Jenkins MK; Waltenbaugh C; Miller SD
    J Immunol; 1985 Jan; 134(1):114-21. PubMed ID: 3155459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection.
    Qian JH; Kokudo S; Sato S; Hamaoka T; Fujiwara H
    Transplantation; 1987 Apr; 43(4):538-43. PubMed ID: 3495052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells.
    Merino J; Schurmans S; Duchosal MA; Izui S; Lambert PH
    J Immunol; 1989 Oct; 143(7):2202-8. PubMed ID: 2570803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.